Innovative Medical Management Co.,Ltd. Stock: price and insider trades · China
创新医疗
No insider purchase over the last 90 days. The latest, by 陈浩东, was filed 08 Jun 2022.
Innovative Medical Management Co.,Ltd.: what insiders have been doing
This page follows insider dealings at Innovative Medical Management Co.,Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of Innovative Medical Management Co.,Ltd. in twelve months, the latest record being from 10 June 2025.
Since 2022, the database holds 1 purchase and 5 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +95.4%Entry CN¥5.61 · Close at T+365 CN¥10.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares0.2% of flowA股XSHESZSE:173000009068764030
- 43,700 shares12.3% of flowA股XSHESZSE:173000006642083940
- 400 shares100.0% of flowA股XSHESZSE:173000005620703400Canonical exit: 6 Sept 2022 (T+90)
- 37,500 shares8.1% of flowA股XSHESZSE:173000005753184130
- 150,000 shares29.7% of flowA股XSHESZSE:173000005400163780
- 272,500 shares49.7% of flowA股XSHESZSE:173000005391354270
6 of 6 declarations
About Innovative Medical Management Co.,Ltd.
Innovation Medical is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
